SLC13A3 - solute carrier family 13 member 3 Gene
Also Known as NaC3; NADC3; SDCT2; ARLIAK
Species: Homo sapiens
About SLC13A3
This gene has 11 transcripts (splice variants), 216 orthologues, 5 paralogues and is associated with 1 phenotype. Biased expression in kidney (RPKM 195.8) and placenta (RPKM 14.9).
Summary
Mammalian sodium-dicarboxylate cotransporters transport succinate and Other Krebs cycle intermediates. They fall into 2 categories based on their substrate affinity: low affinity and high affinity. Both the low- and high-affinity transporters play an important role in the handling of citrate by the kidneys. The protein encoded by this gene represents the high-affinity form. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, although the full-length nature of some of them have not been characterized yet. [provided by RefSeq, Jul 2008]
SLC13A3 Products (5)
| mRNA | Protein | Name |
|---|---|---|
| NM_001011554.3 | NP_001011554.1 | Na(+)/dicarboxylate cotransporter 3 isoform b |
| NM_001193339.2 | NP_001180268.1 | Na(+)/dicarboxylate cotransporter 3 isoform c precursor |
| NM_001193340.2 | NP_001180269.1 | Na(+)/dicarboxylate cotransporter 3 isoform d |
| NM_001193342.2 | NP_001180271.1 | Na(+)/dicarboxylate cotransporter 3 isoform e |
| NM_022829.6 | NP_073740.2 | Na(+)/dicarboxylate cotransporter 3 isoform a precursor |
SLC13A3 Protein Structure
Na_sulph_symp: Sodium:sulfate symporter transmembrane region (10 - 572)
- 0
- 100
- 200
- 300
- 400
- 500
- 602 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
Na(+)/dicarboxylate cotransporter 3 |
|
SLC13A3 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
SLC13A3 | Q8WWT9 | CISD2 | Homo sapiens | Q8N5K1 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | CISD2 | Homo sapiens | Q8N5K1 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | CYB5R3 | Homo sapiens | P00387 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | CYB5R3 | Homo sapiens | P00387 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | RMDN3 | Homo sapiens | Q96TC7 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | RMDN3 | Homo sapiens | Q96TC7 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | RMDN3 | Homo sapiens | Q96TC7 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | ARL13B | Homo sapiens | Q3SXY8 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | ARL13B | Homo sapiens | Q3SXY8 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | GPX8 | Homo sapiens | Q8TED1 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | GPX8 | Homo sapiens | Q8TED1 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | LEUTX | Homo sapiens | A8MZ59 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | LEUTX | Homo sapiens | A8MZ59 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | FAM209A | Homo sapiens | Q5JX71 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | FAM209A | Homo sapiens | Q5JX71 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | CREB3L1 | Homo sapiens | Q96BA8 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | CREB3L1 | Homo sapiens | Q96BA8 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | CREB3L1 | Homo sapiens | Q96BA8 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | ERGIC3 | Homo sapiens | Q9Y282 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | ERGIC3 | Homo sapiens | Q9Y282 | 32296183 | |
|
Intra
|
SLC13A3 | Q8WWT9 | ERGIC3 | Homo sapiens | Q9Y282 | 32296183 |
SLC13A3 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P810033 | NaDC-3 Antibody (YA9377) | WB, IP, ELISA | human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Leukoencephalopathy, Acute Reversible, With Increased Urinary Alpha-Ketoglutarate |
|
|
| Axenfeld-Rieger Syndrome, Type 1 |
|
|
| Canavan Disease |
|
|
| Developmental And Epileptic Encephalopathy 25 |
|
|
| N-Acetylglutamate Synthase Deficiency |
|
|
| Developmental And Epileptic Encephalopathy 39 |
|
|
| L-2-Hydroxyglutaric Aciduria |
|
|
| Glutaric Acidemia I |
|
|
| Axenfeld-Rieger Syndrome |
|
|
| Early Infantile Epileptic Encephalopathy |
|
|